Pancreatic cancer, Secondary cancers
Open
Phase 1/2
This trial is looking at adding VP-002 to gemcitabine and nab-paclitaxel chemotherapy.
It is for people who:
have pancreatic cancer that has spread to other parts of the body ()
are enrolled in another pancreatic cancer study called Precision-Panc
Recruitment start: 4 April 2025
Recruitment end: 1 January 2028
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Bristi Basu
Cambridge University Hospitals NHS Foundation Trust
Cycle Pharmaceuticals
Last reviewed: 26 June 2025
CRUK internal database number: 20013
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
